Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
<p dir="ltr">Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells. A-C) The significantly top-downregulated GO pathways in AD-MSCs (A), PSCs (B), and BM-MSCs (C) after treatment with the KC and KCM serum.</p>
Uloženo v:
| Hlavní autor: | |
|---|---|
| Vydáno: |
2025
|
| Témata: | |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| _version_ | 1849927637244313600 |
|---|---|
| author | Sushil Kumar (20371917) |
| author_facet | Sushil Kumar (20371917) |
| author_role | author |
| dc.creator.none.fl_str_mv | Sushil Kumar (20371917) |
| dc.date.none.fl_str_mv | 2025-11-25T00:35:59Z |
| dc.identifier.none.fl_str_mv | 10.6084/m9.figshare.27948372.v1 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Supplementary_Figure_5_Pathway_analysis_after_treatment_with_KC_and_KCM_serum_in_precursor_cells/27948372 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer cell biology pancreatic cancer stroma epigenetics CAF heterogeniety Muc5ac |
| dc.title.none.fl_str_mv | Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p dir="ltr">Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells. A-C) The significantly top-downregulated GO pathways in AD-MSCs (A), PSCs (B), and BM-MSCs (C) after treatment with the KC and KCM serum.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_0ce7d594a339f3b328a34788a181ce7e |
| identifier_str_mv | 10.6084/m9.figshare.27948372.v1 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/27948372 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cellsSushil Kumar (20371917)Cancer cell biologypancreatic cancerstromaepigeneticsCAF heterogenietyMuc5ac<p dir="ltr">Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells. A-C) The significantly top-downregulated GO pathways in AD-MSCs (A), PSCs (B), and BM-MSCs (C) after treatment with the KC and KCM serum.</p>2025-11-25T00:35:59ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.6084/m9.figshare.27948372.v1https://figshare.com/articles/figure/Supplementary_Figure_5_Pathway_analysis_after_treatment_with_KC_and_KCM_serum_in_precursor_cells/27948372CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/279483722025-11-25T00:35:59Z |
| spellingShingle | Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells Sushil Kumar (20371917) Cancer cell biology pancreatic cancer stroma epigenetics CAF heterogeniety Muc5ac |
| status_str | publishedVersion |
| title | Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells |
| title_full | Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells |
| title_fullStr | Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells |
| title_full_unstemmed | Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells |
| title_short | Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells |
| title_sort | Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells |
| topic | Cancer cell biology pancreatic cancer stroma epigenetics CAF heterogeniety Muc5ac |